Senzime AB of Uppsala at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Senzime AB

Ulls väg 29B, 756 51 Uppsala
Telephone +46 18 515640
Fax +46 18 515630

Hall map

MEDICA 2018 hall map (Hall 11): stand F66

Fairground map

MEDICA 2018 fairground map: Hall 11

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.06  Intense medicine / anesthesiology / respiration
  • 01.06.03  Patient monitoring systems

Patient monitoring systems

Our products

Product category: Patient monitoring systems

The next generation TOF-monitor

  • The arm can be tucked under surgical drape, no thumb access required
  • Less than 30 seconds start-up, no calibration needed
  • Ease of use with single-use electro-sensors and no cross-contamination
  • Precise & reliable information based on EMG technique
The new TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents (NMBAs). The sequence is performed in real-time, and the system requires less than 30 sec. for set-up.

The unique, user-friendly system includes the TetraGraph monitor, TetraSens disposable electrosensors and the TetraCord connecting cable.

More Less

About us

Company details

About us
  • Senzimes solutions are designed to ensure maximum patient benefit
  • Reduce complications associated with surgery
  • Reduce health care costs
Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients’ biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting.

The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The Senzime AB (publ) share are listed on NASDAQ Stockholm First North. Short name: SEZI.

More Less